Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axogen Inc (AXGN)

Axogen Inc (AXGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axogen Inc 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 USA

www.axogeninc.com Employees: 452 P: 386-462-6800 F: 386-462-6801

Sector:

Medical

Description:

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,469,908
Enterprise Value, $K 1,483,858
Shares Outstanding, K 46,122
Float, K 44,840
% Float 97.22%
Short Interest, K 2,685
Short Float 5.82%
Days to Cover 3.78
Short Volume Ratio 0.38
% of Insider Shareholders 2.78%
% of Institutional Shareholders 80.29%

Financials:

Annual Sales, $ 187,340 K
Annual Net Income, $ -9,960 K
Last Quarter Sales, $ 60,080 K
Last Quarter Net Income, $ 710 K
EBIT, $ 3,940 K
EBITDA, $ 12,670 K

Growth:

1-Year Return 74.01%
3-Year Return 223.31%
5-Year Return 90.26%
5-Year Revenue Growth 75.56%
5-Year Earnings Growth 66.18%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.12 on 10/29/25
Next Earnings Date 02/24/26
Earnings Per Share ttm -0.05
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 125.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 1.000 on 01/27/10
Dividend Payable Date 02/12/10
Dividend Payout Ratio 0.00%

AXGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 182.47
Price/Earnings to Growth N/A
Return-on-Equity % -1.90%
Return-on-Assets % -1.02%
Profit Margin % -5.32%
Debt/Equity 0.40
Price/Sales 7.07
Price/Cash Flow N/A
Price/Book 11.84
Book Value/Share 2.62
Interest Coverage -0.21
60-Month Beta 1.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar